1 |
Kim YK, Cho SI, Park HS. Obesity as a related factor of poor antibody response to hepatitis B vaccine. Korean J Obes 2003;12:245-51.
|
2 |
Simo Minana J, Gaztambide Ganuza M, Fernandez Millan P, Pena Fernandez M. Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine 1996;14:103-6.
DOI
|
3 |
Korea Centers for Disease Control & Prevention. Seroepidemiology of hepatitis B among preschool children in Korea. Public Health Wkly Rep 2008;1:173-7.
|
4 |
Korea Centers for Disease Control & Prevention. Achieving the regional goal of the hepatitis B control in Korea. Public Health Wkly Rep 2008;1:273-7.
|
5 |
Ahn YO, Kim CY, Bae SH, Chang HG. Changing pattern of HBV-related diseases in Korea since after HBV vaccination. Clin Mol Hepatol 2010;16:S23-37.
|
6 |
Zhao H, Zhou YH. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no? Hum Vaccin Immunother 2018;14:456-63.
DOI
|
7 |
Seo JH. Hepatitis B surface antigen and antibody positive rates of children and adolescents in Jeju. Taehan Kan Hakhoe Chi 2003;9: 304-14.
|
8 |
Kim YJ, Li P, Hong JM, Ryu KH, Nam E, Chang MS. A single center analysis of the positivity of hepatitis B antibody after neonatal vaccination program in Korea. J Korean Med Sci 2017;32:810-6.
DOI
|
9 |
Van Der Meeren O, Behre U, Crasta P. Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine. Vaccine 2016;34:2745-9.
DOI
|
10 |
Spada E, Romano L, Tosti ME, Zuccaro O, Paladini S, Chironna M, et al. Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study. Clin Microbiol Infect 2014;20:O680-6.
DOI
|
11 |
Jouneghani AS, Chaleshtori MH, Khoshdel A, Kheiri S, Farrokhi E, Khalafian P, et al. Evaluation of response to hepatitis B vaccine in Iranian 6-18-year-old students. J Res Med Sci 2017;22:116.
DOI
|
12 |
Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985;254:3187-9.
DOI
|
13 |
Kabir A, Pazouki A, Jafari M, Mokhber S, Vaziri M, Alavian SM. Comparing anti-hepatitis B antibody level in iranian obese or overweight with non-obese cases. Iran Biomed J 2017;21:197-202.
DOI
|
14 |
Fan W, Chen XF, Shen C, Guo ZR, Dong C. Hepatitis B vaccine response in obesity: a meta-analysis. Vaccine 2016;34:4835-41.
DOI
|
15 |
Korea Centers for Disease Control and Prevention, Division of Health and Nutrition Survey; Korean Pediatric Society, Committee for School Health and Public Health Statistics; Committee for the Development of Growth Standards for Korean Children and Adolescents. 2017 Korean National Growth Charts for children and adolescents. Cheongju (Korea): Korea Centers for Disease Control and Prevention, 2017.
|
16 |
The Korean Pediatric Society. Immunization guideline. Seoul: The Korean Pediatric Society, 2018.
|
17 |
Young KM, Gray CM, Bekker LG. Is obesity a risk factor for vaccine non-responsiveness? PLoS One 2013;8:e82779.
DOI
|
18 |
Shaw FE Jr, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989;7:425-30.
DOI
|
19 |
Poirier MK, Poland GA, Jacobson RM. Parameters potentially affecting interpretation of immunogenicity and efficacy data in vaccine trials: are they adequately reported? Vaccine 1996;14:25-7.
DOI
|
20 |
Poland GA, Borrud A, Jacobson RM, McDermott K, Wollan PC, Brakke D, et al. Determination of deltoid fat pad thickness. Implications for needle length in adult immunization. JAMA 1997;277:1709-11.
DOI
|
21 |
Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-52.
|
22 |
Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006; 39:137-41.
DOI
|
23 |
Banga N, Guss P, Banga A, Rosenman KD. Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students. Vaccine 2014;32: 979-83.
DOI
|
24 |
Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med (Maywood) 2010;235:1412-24.
DOI
|
25 |
Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine 2015;33:4422-9.
DOI
|
26 |
Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc 2012;71:298-306.
DOI
|